Kezdőlap・Részvénylista・Ocugen Inc

Ocugen Inc

Lezárt

1.21 -4.72

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1.21

Maximum

1.27

Fő mutatók
By Trading Economics
Bevétel	-1.5M -19M
Értékesítés	1.7M 1.5M
Egy részvényre jutó nyereség	-0.06
Profit margin	-1,250.946
Munkavállalók	116
EBITDA	-987K -17M

Ajánlások
By TipRanks
Ajánlások	Erős vétel
12 hónapos előrejelzés	+661.42% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. júl. 31.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-176M 450M
Előző nyitás	5.93
Előző zárás	1.21

Ocugen Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. júl. 24. 23:56 UTC

Fox Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains stable within its one-month trading range.

2026. júl. 24. 23:56 UTC

Lumen Technologies Inc shares are higher in after-market trading, continuing fluctuations despite a broader trend of declines over the past month. No specific news identified.

2026. júl. 24. 23:56 UTC

Correlated Moves

State Street Corp shares are lower in after-market trading, reflecting broader market dynamics amid turmoil in the bond markets and sector trends.

2026. júl. 24. 23:56 UTC

Wingstop Inc. shares are higher in after-market trading, recovering from an earlier dip. The stock remains near the lower end of its one-month range.

2026. júl. 24. 23:56 UTC

Cracker Barrel Old Country Store shares are lower in after-market hours. No specific news was identified to explain the decline amid broader market conditions.

2026. júl. 24. 23:56 UTC

Carpenter Technology Corp shares are lower in after-market trading, reflecting broader market trends amid rising concerns in the bond markets.

2026. júl. 24. 23:56 UTC

CMS Energy shares are higher in after-market trading following a slight pullback earlier in the session. The stock has advanced since Friday's close.

2026. júl. 24. 23:56 UTC

DocuSign Inc shares are lower in after-market hours, reflecting a slight decline since Friday's close amid narrow trading fluctuations and no specific news.

2026. júl. 24. 23:56 UTC

JD.Com shares were lower in after-market trading, despite briefly peaking shortly after market open. The stock remains near the upper end of its one-month range.

2026. júl. 24. 23:56 UTC

Correlated Moves

Ares Capital Corp shares declined slightly in after-market trading, reflecting broader financial sector trends amid turmoil in bond markets and rising spreads.

2026. júl. 24. 23:56 UTC

Correlated Moves

ON Semiconductor shares are higher in after-market trading, tracking MACOM's advance. The stock remains near the lower end of its one-month range.

2026. júl. 24. 23:56 UTC

Aptiv PLC shares are trading higher in after-market hours, remaining near the lower end of their one-month trading range. No specific news was identified.

2026. júl. 24. 23:56 UTC

The iShares MSCI South Korea ETF is trading lower in after-market hours, continuing a decline since Friday's close. No specific news was identified.

2026. júl. 24. 23:52 UTC

S&P/Case-Shiller Home Price Index Set to Show 5.2% Increase Amid Mixed Economic Sentiment and Rising Inflation Concerns

2026. júl. 24. 23:52 UTC

South Africa's Upcoming Balance of Trade Data Sparks Caution Amid First Trade Deficit and Global Supply Chain Tensions.

2026. júl. 24. 23:51 UTC

UnitedHealth Group Inc shares are lower in after-market hours, continuing a decline since Friday's close amid broader market trends. No specific news was identified.

2026. júl. 24. 23:51 UTC

Wendy's Co shares are higher in after-market hours, continuing an upward trend from earlier in the session, despite no specific news driving the move.

2026. júl. 24. 23:51 UTC

Pilgrim's Pride Corp shares are higher in after-market trading, continuing gains from Friday's close and nearing the upper end of their one-month trading range.

2026. júl. 24. 23:51 UTC

Axon Enterprise Inc shares are trading lower in after-market hours, reaching a session low amid broader turmoil in bond markets affecting credit investors.

2026. júl. 24. 23:51 UTC

Clear Secure Inc shares are higher in after-market trading, recovering from an initial dip. The stock remains near the lower end of its one-month range.

2026. júl. 24. 23:51 UTC

indie Semiconductor Inc. shares were roughly flat in after-market hours, following four consecutive daily declines amid ongoing market challenges.

2026. júl. 24. 23:51 UTC

Howmet Aerospace Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains. No specific news was identified for the move.

2026. júl. 24. 23:51 UTC

Trimble Inc shares are higher in after-market trading, showing resilience despite challenging macroeconomic conditions and no specific company news identified.

2026. júl. 24. 23:51 UTC

Constellation Brands Inc shares are higher in after-market hours, reflecting modest gains since Friday's close despite broader bond market turmoil.

2026. júl. 24. 23:51 UTC

East West Bancorp Inc shares are higher in after-market trading, reflecting notable strength since Friday's close, with no specific news identified.

2026. júl. 24. 23:51 UTC

U.S. equity indices remain flat as investors weigh mixed earnings, geopolitical tensions, and a surprising drop in jobless claims amidst rising oil prices.

2026. júl. 24. 23:51 UTC

Global equity markets show mixed performance as European indices rise on positive economic data, while Asian markets decline amid geopolitical tensions and rising oil prices.

2026. júl. 24. 23:51 UTC

European equity indices rebound on strong PMI data, while Asian markets decline amid rising oil prices and geopolitical tensions.

2026. júl. 24. 23:51 UTC

Asian equity markets decline amid rising oil prices and geopolitical tensions, while Germany's DAX rises; U.S. stocks remain flat as investors await key economic data.

2026. júl. 24. 23:51 UTC

Axsome Therapeutics Inc shares are lower in after-market hours, reflecting a notable decline since Friday's close, with no specific news identified.

Társak összehasonlítása

Árváltozás

Ocugen Inc Előrejelzés

Célár

By TipRanks

661.42% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 9.67 USD 661.42%

Magas 12 USD

Alacsony 7 USD

6 Wall Street elemző 12 hónapos célárain alapulva a(z)Ocugen Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

6 ratings

Vétel

Tartás

Eladás

6 Wall Street elemző célárain alapulva a(z)Ocugen Inc termékhez az elmúlt 3 hónapban.

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.